To examine whether
amiloride protects against
ischemia-induced or reperfusion-induced damage to the heart, mechanical and metabolic studies were performed in the isolated, working rat heart.
Ischemia decreased both mechanical function and the tissue levels of high-energy
phosphates and increased the tissue levels of
free fatty acids (FFAs). Reperfusion restored the levels of high-energy
phosphates but further increased FFA accumulation. For this reason, accumulation of FFAs was used as an
indicator of both
ischemia-induced and reperfusion-induced damage. Drugs were added to the perfusion
solution 5 min before
ischemia until the end of
ischemia (pre) or until 10 min after reperfusion (pre + post).
Diltiazem (1 or 5 mumol/L pre) decreased the mechanical function of the non-ischemic heart and attenuated both
ischemia-induced and reperfusion-induced accumulation of FFAs.
Amiloride (50 mumol/L pre) did not affect the mechanical function of the non-ischemic heart or attenuate
ischemia-induced or reperfusion-induced FFA accumulation effectively. However,
amiloride (50 mumol/L pre + post) did markedly attenuate the reperfusion-induced accumulation of FFAs. In conclusion,
diltiazem attenuates both
ischemia-induced and reperfusion-induced myocardial damage, probably through its energy-sparing effect as a result of a decrease in mechanical function before
ischemia. In contrast,
amiloride attenuates only the reperfusion-induced myocardial damage through mechanisms other than the energy-sparing effect.